Literature DB >> 8297645

Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group.

J A van Unnik1, J M Coindre, C Contesso, C E Albus-Lutter, T Schiodt, R Sylvester, D Thomas, V Bramwell, H T Mouridsen.   

Abstract

A practical grading system for soft tissue sarcomas was developed, based on 282 eligible patients entered in an EORTC adjuvant clinical trial. The primary tumours in this trial had to be adequately treated. Histopathological parameters, which appeared significant in two preceding studies, were tested. These parameters were differentiation of the tumour, presence and amount of necrosis, the presence and amount of myxoid areas and the number of mitoses. In addition, the size of the tumour was also analysed. The quantitative data (mitotic count and size of the tumour) were not a priori grouped, but were divided into categories based on the results of the statistical analysis. Based on a multivariate analysis only mitotic count, the presence or absence of necrosis and the size of the tumour were significantly correlated with the duration of survival or the time to distant metastases. Of these parameters, the mitotic count was the most important.

Entities:  

Mesh:

Year:  1993        PMID: 8297645     DOI: 10.1016/0959-8049(93)90039-i

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

Review 1.  Proliferation markers in tumours: interpretation and clinical value.

Authors:  P J van Diest; G Brugal; J P Baak
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

2.  Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

Authors:  P Rudolph; U Kellner; A Chassevent; F Collin; F Bonichon; R Parwaresch; J M Coindre
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  miR-199a-5p regulates HIF-1α and OSGIN2 and its expression is correlated to soft-tissue sarcoma patients' outcome.

Authors:  Jacqueline Keßler; Swetlana Rot; Matthias Bache; Matthias Kappler; Peter Würl; Dirk Vordermark; Helge Taubert; Thomas Greither
Journal:  Oncol Lett       Date:  2016-10-26       Impact factor: 2.967

4.  Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.

Authors:  Wolfgang P Fendler; Rebecca P Chalkidis; Harun Ilhan; Thomas Knösel; Ken Herrmann; Rolf D Issels; Peter Bartenstein; Clemens C Cyran; Lars H Lindner; Marcus Hacker
Journal:  Eur Radiol       Date:  2015-02-19       Impact factor: 5.315

5.  [Histological grading of soft tissue sarcomas: stratification of G2-sarcomas in low- or high-grade malignant tumors].

Authors:  P Meister
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

Review 6.  A guide to oncological management of soft tissue tumours of the abdominal wall.

Authors:  K J Williams; A J Hayes
Journal:  Hernia       Date:  2013-09-17       Impact factor: 4.739

7.  Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients.

Authors:  Helge Taubert; Chris Heidenreich; Hans-Jürgen Holzhausen; Antje Schulz; Matthias Bache; Matthias Kappler; Alexander W Eckert; Peter Würl; Ingo Melcher; Kathrin Hauptmann; Steffen Hauptmann; Klaus-Dieter Schaser
Journal:  BMC Cancer       Date:  2010-02-24       Impact factor: 4.430

8.  Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.

Authors:  Matthias Bache; Matthias Kappler; Henri Wichmann; Swetlana Rot; Antje Hahnel; Thomas Greither; Harun M Said; Matthias Kotzsch; Peter Würl; Helge Taubert; Dirk Vordermark
Journal:  BMC Cancer       Date:  2010-04-08       Impact factor: 4.430

9.  Diagnosis and treatment of soft tissue tumours: the dutch nationwide-accepted consensus.

Authors:  A N Van Geel; J A Van Unnik; R B Keus
Journal:  Sarcoma       Date:  1998

10.  Should tumor depth be included in prognostication of soft tissue sarcoma?

Authors:  Anders Rydholm; Pelle Gustafson
Journal:  BMC Cancer       Date:  2003-05-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.